Unable to load price data. Sorry.

¯\_(ツ)_/¯

Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

CAPS Rating: No stars

A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

153 Outperform
29 Underperform
 

All-Star Players

17 Outperform
7 Underperform
 

Wall Street

7 Outperform
3 Underperform
 

Top NASDAQ:SNTA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cibient (< 20)
Submitted February 04, 2010

Surge of insider buying inspires confidence. While this means nothing if the drug ultimately doesn't fly, or heavy dilution tramples existing shareholders, the company has a good balance sheet due to the recent capital raise.

zzlangerhans (99.83)
Submitted October 18, 2013

There's always that one last moment of hesitation before I hit the underperform button on an oncology stock in CAPS. Last chance to avoid making a fool of myself focusing on the corpse of a failed lead drug and completely unaware of the hot new… More

NASDAQ:SNTA VS S&P 500 (SPY)

Fools bullish on NASDAQ:SNTA are also bullish on:

Fools bearish on NASDAQ:SNTA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SNTA.

Recs

0
Member Avatar joienpaix (< 20) Submitted: 3/18/2015 6:22:12 PM : Outperform Start Price: $2.36 NASDAQ:SNTA Score: -124.70

2016 Q2

Recs

0
Member Avatar pchop123 (82.64) Submitted: 7/18/2014 6:41:03 PM : Outperform Start Price: $4.11 NASDAQ:SNTA Score: -139.98

watch their Ph III Study

Recs

0
Member Avatar swingtrader858 (< 20) Submitted: 5/12/2014 8:01:58 PM : Outperform Start Price: $4.23 NASDAQ:SNTA Score: -151.36

HUGE insider purchases. A great sign for a biopharm or biotech company. Buying in the $4's provides a great risk/reward ratio, as so much support plus insider purchases at these levels. Target $6 by end of 2014.

Leaderboard

Find the members with the highest scoring picks in SNTA.

Score Leader

TrackWellsFargo

TrackWellsFargo (88.06) Score: +379.24

The Score Leader is the player with the highest score across all their picks in SNTA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
MicroCaptain < 20 1/29/2010 Underperform 1Y $4.30 -92.02% +166.56% +258.59 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $5.49 -93.75% +164.04% +257.79 0 Comment
dgu004 96.90 12/22/2009 Underperform 3Y $6.50 -94.72% +162.02% +256.75 1 Comment
bigdave1985 56.34 12/23/2009 Underperform 3W $5.65 -93.93% +161.02% +254.95 0 Comment
usc4life 68.72 12/23/2009 Underperform 5Y $5.65 -93.93% +161.02% +254.95 0 Comment
marcet 72.22 6/10/2011 Underperform 5Y $5.10 -93.27% +126.88% +220.16 0 Comment
vinoteca 61.54 6/25/2012 Underperform NS $7.30 -95.30% +121.39% +216.69 0 Comment
ShiningTime 31.11 5/21/2012 Underperform 5Y $3.83 -91.04% +124.60% +215.64 0 Comment
PureStyle 29.96 5/21/2012 Underperform 5Y $3.83 -91.04% +124.60% +215.64 0 Comment
SharesNoFutures 33.20 5/21/2012 Underperform 5Y $3.83 -91.04% +124.60% +215.64 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 91.44 3/12/2014 Underperform NS $4.36 -92.13% +56.90% +149.04 0 Comment
TrackJMP 84.61 7/16/2013 Outperform NS $5.84 -94.13% +73.74% -167.87 0 Comment
TrackPoisedTo < 20 2/19/2013 Underperform 5Y $9.40 -96.35% +91.86% +188.21 0 Comment
TrackBMOCapital < 20 6/4/2012 Outperform NS $5.39 -93.63% +127.70% -221.33 0 Comment
TrackRodmanRen < 20 1/5/2012 Outperform NS $4.94 -93.06% +130.17% -223.23 0 Comment
TrackCanaccord 66.51 2/28/2011 Outperform NS $5.66 -93.94% +119.92% -213.86 0 Comment
trackmlvcapital < 20 11/9/2010 Outperform NS $3.55 -90.34% +138.02% -228.36 0 Comment
TrackMorganJos 72.25 8/26/2010 Outperform NS $2.90 -88.17% +174.65% -262.82 0 Comment
TrackRothCapital 61.03 5/10/2010 Outperform NS $3.41 +71.55% +16.92% +54.64 5/3/2011 @ $5.85 0 Comment
TrackJGreenblatt 46.13 4/13/2010 Outperform 1Y $4.42 +31.67% +11.62% +20.05 4/25/2011 @ $5.82 1 Comment
TrackRothCapital 61.03 11/5/2009 Outperform NS $2.80 +41.43% +4.35% +37.07 2/17/2010 @ $3.96 0 Comment
TrackWellsFargo 88.06 2/27/2009 Underperform NS $1.51 -77.28% +301.96% +379.24 0 Comment
TrackSusquehanna 84.38 6/2/2008 Outperform NS $7.20 -95.24% +116.81% -212.05 0 Comment
TrackRothCapital 61.03 4/9/2008 Outperform NS $7.88 -80.84% -45.76% -35.08 2/27/2009 @ $1.51 0 Comment
TrackFBRCapitalM 86.02 3/12/2008 Outperform NS $7.00 -12.86% -3.79% -9.07 6/30/2008 @ $6.10 0 Comment
TrackRBCCapMkts 84.39 1/31/2008 Outperform NS $7.23 -79.11% -44.45% -34.66 2/27/2009 @ $1.51 0 Comment
TrackRodmanRen < 20 10/2/2007 Outperform NS $8.06 -81.27% -52.07% -29.19 2/27/2009 @ $1.51 0 Comment
TrackLazardCapit 29.11 3/19/2007 Outperform NS $9.50 -84.11% -46.87% -37.23 2/27/2009 @ $1.51 0 Comment
TrackBearStearns < 20 3/19/2007 Outperform NS $9.85 -59.59% -0.85% -58.74 4/17/2012 @ $3.98 0 Comment